Page last updated: 2024-09-04

beta-lactams and Pneumonia, Bacterial

beta-lactams has been researched along with Pneumonia, Bacterial in 121 studies

Research

Studies (121)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.83)	18.2507
2000's	41 (33.88)	29.6817
2010's	71 (58.68)	24.3611
2020's	8 (6.61)	2.80

Authors

Authors	Studies
Al-Salloum, J; Gillani, SW; Gulam, SM; Mahmood, RK	1
Bae, S; Chang, HH; Hwang, S; Jeon, Y; Kim, SW; Kim, Y; Kwon, KT; Lee, WK; Shim, EK; Shin, JH; Yang, KH	1
Arulkumaran, N; Cesar, A; Choi, SH; Saleem, N; Singer, M; Snow, TAC	1
Cao, X; Forstner, C; Kolditz, M; König, R; Oswald, M; Pletz, M; Rohde, G; Rupp, J; Welte, T; Witzenrath, M	1
Anzueto, A; Brozek, J; Cooley, LA; Crothers, K; Dean, NC; Fine, MJ; Flanders, SA; Griffin, MR; Long, AC; Metersky, ML; Metlay, JP; Musher, DM; Restrepo, MI; Waterer, GW; Whitney, CG	1
Adami, ME; Alexiou, N; Giamarellos-Bourboulis, EJ; Gogos, C; Halvatzis, S; Kosmas, V; Koutoukas, P; Kyprianou, A; Kyprianou, M; Kyriakoudi, A; Kyriazopoulou, E; Lada, M; Makina, A; Niederman, MS; Pavlaki, M; Sinapidis, D; Stefos, A; Velissaris, D	1
Ishida, T; Ito, A; Tachibana, H; Tokumasu, H; Washio, Y; Yamazaki, A	1
Bodtger, U; Eklöf, J; Gliese, KM; Ingebrigtsen, TS; Jensen, JS	1
Al Saeedy, D; Al-Salloum, J; Eissa, M; Gillani, SW; Gulam, SM; Moosvi, A	1
Irie, H; Ishida, T; Ito, A; Nakanishi, Y; Otake, T; Tachibana, H; Tokioka, F; Washio, Y; Yamazaki, A	1
Averjanovaitė, V; Cincilevičiūtė, G; Danila, E; Mereškevičienė, R; Pliatkienė, G; Zablockis, R	1
Fekete, T	2
Economou, CJP; Lipman, J; McWhinney, B; Roberts, JA; Ungerer, JPJ; Wong, G	1
Bonten, MJM; Oosterheert, JJ; Postma, DF; Schweitzer, VA; van Smeden, M; van Werkhoven, CH	1
Abraham, I; Al Mohajer, M; Aljabri, A; Alshehri, S; Eljaaly, K; Kalil, AC; Nix, DE	1
Adamzik, M; Asmussen, S; Karlik, J; Peters, J; Rahmel, T; Steinmann, J	1
Arnold, FW; Bordon, J; Cavallazzi, R; Feldman, C; Fernandez-Botran, R; Mattingly, WA; Metersky, ML; Peyrani, P; Ramirez, JA; Wiemken, TL	1
Bousquet-Melou, A; Ferran, AA; Lacroix, MZ; Toutain, PL; Vasseur, MV	1
Baptista, JP; Froes, F; Gonçalves-Pereira, J; Paiva, JA; Pereira, JM; Ribeiro, O	1
Ampofo, K; Anderson, EJ; Arnold, SR; Bramley, AM; Edwards, KM; Grijalva, CG; Hicks, LA; Jain, S; McCullers, JA; Pavia, AT; Self, WH; Williams, DJ; Zhu, Y	1
Waterer, G	1
Al-Hasan, MN; Al-Jaghbeer, MJ; Bookstaver, PB; Hucks, J; Justo, JA; Kohn, J; Owens, W	1
Bonten, MJM; Oosterheert, JJ; Postma, DF; Spitoni, C; van Elden, LJR; van Werkhoven, CH	1
Hatakeyama, S; Matsui, H; Morisawa, Y; Sasabuchi, Y; Sasahara, T; Suzuki, J; Yamada, T; Yasunaga, H	1
Beardsley, JR; Johnson, JW; Koliscak, LP; Luther, VP; Miller, DP; Ohl, CA; Williamson, JC	1
Arnold, C; Bassetti, S; Piso, RJ	1
Adrie, C; Azoulay, E; Darmon, M; Dinh-Xuan, AT; Garrouste-Orgeas, M; Jamali, S; Kallel, H; Planquette, B; Schwebel, C; Souweine, B; Timsit, JF; Vignoud, L; Zahar, JR	1
Doi, Y; Qureshi, ZA; Syed, A	1
Bonten, MJ; Oosterheert, JJ; Postma, DF; van Werkhoven, CH	1
Belova, VV; Bulovskaia, LN; Erbasskaia, AV; Govorova, LV; Ivanova, VV	1
Fine, MJ; Lee, JS	1
Carballo, S; Chuard, C; Eich, G; Garin, N; Genné, D; Harbarth, S; Hugli, O; Lamy, O; Nendaz, M; Perneger, T; Perrier, A; Petignat, PA; Rutschmann, O; Seravalli, L	1
Maraki, S; Papadakis, IS	1
Boersma, WG; Bonten, MJ; Compaijen, CJ; Hoepelman, AI; Kluytmans, JA; Oosterheert, JJ; Postma, DF; Prins, JM; Thijsen, SF; van der Wall, E; van Elden, LJ; van Werkhoven, CH	1
Ambroggio, L; Blosky, MA; Graf, TR; Macaluso, M; Metlay, JP; Shah, SS; Test, M	2
Paul, M; Raz-Pasteur, A; Shasha, D	1
Kern, WV	1
Mandell, LA; Waterer, GW	1
Bonten, MJ; Postma, DF; van Werkhoven, CH	1
van der Eerden, MM	1
Partlow, E; Piszczek, J	1
Kearns, RJ; Kinsella, J	1
Li, B; Nie, W	1
Hasler, S	1
Emmet O'Brien, M; Martin-Loeches, I; Restrepo, MI	1
Chan, YL; Chang, SS; Hsu, SM; Lee, CC; Lee, MG; Lee, SH; Pang, L	1
Ellidokuz, H; Kılıç Soylar, Ö; Kılınç, O	1
Cprek, JB; Gallagher, JC	1
Hatta, Y; Hirabayashi, Y; Hojo, A; Iriyama, N; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kurita, D; Kusuda, M; Miura, K; Nakagawa, M; Ohtake, S; Sakagami, M; Takahashi, H; Takei, M; Uchino, Y	1
Bassetti, M; Welte, T; Wunderink, RG	1
Artero, A; Atienza, A; Correa, S; Faus, A; López, I; Madrazo, M; Puchades, F	1
Haranaga, S; Higa, F; Horita, N; Kaneko, T; Kohno, S; Miki, M; Miyashita, N; Namkoong, H; Otsuka, T; Takahashi, H; Yoshida, M	1
Ortega G, M; Reyes B, T; Saldías P, F	1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N	1
Arnold, FW	1
Kaysin, A; Viera, AJ	1
Falagas, ME; Trigkidis, KK; Vardakas, KZ	1
Galanis, I; Granath, F; Hedlund, J; Naucler, P; Rhedin, S; Spindler, C; Ternhag, A	1
Bonten, MJ; Mangen, MJ; Oosterheert, JJ; Postma, DF; van Werkhoven, CH	1
Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF	1
Arguedas, A; Blumer, J; Botet, FA; Cespedes, J; Gesser, R; Snyder, T; Wang, J; West, J; Wimmer, W; Yogev, R	1
File, TM	1
Marre, R; Martus, P; Schnoor, M; Suttorp, N; Tessmer, A; Welte, T	1
Marco, JA; Naranjo, OR; Rodríguez de Castro, F; Violán, JS	1
Gómez del Valle, C; Matía, M; Pérez-Calvo, JI; Torralba, MÁ	1
Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H	1
Burkhardt, O; Derendorf, H; Kielstein, JT; Kumar, V; Schmidt, S; Welte, T	1
An, MM; Cao, YB; Gao, PH; Jiang, YY; Shen, H; Zou, Z	1
Bai, L; Cao, B; Gonzalez, R; Guo, P; Liu, YM; Ren, LL; Song, SF; Wang, C; Wang, JW; Yin, YD; Zhang, JZ; Zhang, YY; Zhao, F	1
Daoud, E; Guzman, J	1
Ewig, S; Hecker, H; Marre, R; Suttorp, N; Welte, T	1
Alaniz, C; Carver, PL; DePestel, DD; Newton, D; Pleva, M; Pogue, JM	1
Lemonovich, TL; Watkins, RR	1
Sakata, H	1
Charles, PG; Grayson, ML; Johnson, PD; Teh, B	1
Asadi, L; Eurich, DT; Gamble, JM; Majumdar, SR; Marrie, TJ; Minhas-Sandhu, JK	1
Chalumeau, M; Cohen, JF; Gendrel, D; Lecarpentier, T; Leis, A; Raymond, J	1
Anzueto, A; Mortensen, EM; Pugh, MJ; Restrepo, MI; Wilson, BZ	2
Mathieu, D; Nseir, S	1
Ambroggio, L; Evans, AA; Newschaffer, CJ; Shah, SS; Tabb, LP; Taylor, JA	1
Alfandari, S; Georges, H; Meybeck, A	1
Mildvan, D; Ruhe, J	1
Bartizal, KF; Hicks, PS; Motyl, M; Pelak, B; Woods, GL	1
Holmberg, H; Sjöberg, L; Stralin, K	1
Carides, A; Friedland, I; Isaacs, R; Ortiz-Ruiz, G; Vetter, N; Woods, GL	1
DiNubile, MJ; Friedland, IR; McCarroll, KA; Woods, GL	1
Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F	1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W	1
Verheij, TJ; Woodhead, M	1
Arrol, B; Mills, GD; Oehley, MR	1
Garau, J	1
Burgess, DS; Frei, CR	2
Granizo Martínez, JJ	1
Anzueto, A; Mortensen, EM; Pugh, J; Restrepo, MI	1
Brink, AJ; Elliott, E; Els, Z; Livermore, DM; Turton, J; van Greune, J; Warner, M; Woodford, N	1
Loh, LC	1
Albertí, S; Alonso, D; Borrell, N; Doménech-Sánchez, A; Gomez, C; Padilla, E; Pérez, JL	1
Li, H; Liu, JH; Ouyang, XL; Wang, QL; Yang, L	1
Ewig, S; Ostendorf, U; Torres, A	1
Krause, R; Laferl, H; Széll, M; Wenisch, C	1
Kohlhammer, Y; Marre, R; Raspe, H; Schäfer, T; Suttorp, N; Welte, T	1
Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV	1
Halank, M; Höffken, G; Kolditz, M	1
Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK	1
Falagas, ME; Manta, KG; Siempos, II; Vardakas, KZ	1
Almanasreh, N; Andreassen, S; Cauda, R; Frank, U; Gafter-Gvili, A; Goldberg, E; Leibovici, L; Nielsen, AD; Paul, M; Tacconelli, E	1
Dimopoulos, G	1
Cremades Romero, MJ; Martínez Moragón, E; Martínez Tomas, R; Menéndez Villanueva, R; Reyes Calzada, S; Soler Cataluña, JJ	1
Cosler, L; Gupta, R; Kwa, A; Lodise, TP; Smith, RP	1
Llor, C	1
Beloborodov, VB; Eliseeva, EV; Grigor'ev, KB; Iakovlev, SV; Iakovlev, VP; Kon, EM; Kostina, GV; Kuprenkov, AV; Levit, AL; Mukhacheva, SIu; Saturnov, AV; Sergeev, IN; Sidorenko, SV; Spasov, GP; Stakanov, AV; Ushakova, MA	1
Leibovici, L; Paul, M; Robenshtock, E	1
Joseph, J; Rodvold, KA	1
Barcelona, L; Marín, M; Stamboulian, D	1
Carbon, C; Farinotti, R; Joly-Guillou, ML; Wolff, M	1
Caballero-Lopez, J; Carides, A; Friedland, IR; Ortiz-Ruiz, G; Woods, GL	1
Akova, M	1

Reviews

24 review(s) available for beta-lactams and Pneumonia, Bacterial

Article	Year
Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review. The Journal of international medical research, 2021, Volume: 49, Issue:10 Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Community-Acquired Infections; Humans; Pneumonia, Bacterial	2021
Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials. International journal of antimicrobial agents, 2023, Volume: 62, Issue:3 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Humans; Macrolides; Pneumonia, Bacterial; Randomized Controlled Trials as Topic	2023
Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review. Current pediatric reviews, 2020, Volume: 16, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Child; Drug Therapy, Combination; Humans; Macrolides; Pneumonia, Bacterial	2020
Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis. BMC infectious diseases, 2017, 06-02, Volume: 17, Issue:1 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Humans; Macrolides; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Failure	2017
Rothia mucilaginosa pneumonia: a literature review. Infectious diseases (London, England), 2015, Volume: 47, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Hematologic Neoplasms; Humans; Immunocompetence; Immunocompromised Host; Lung; Male; Micrococcaceae; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography; Vancomycin	2015
Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis. International journal of antimicrobial agents, 2015, Volume: 46, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Humans; Macrolides; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Failure; Treatment Outcome; Withholding Treatment	2015
Update on the combination effect of macrolide antibiotics in community-acquired pneumonia. Respiratory investigation, 2015, Volume: 53, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Host-Pathogen Interactions; Humans; Immunomodulation; Macrolides; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Severity of Illness Index	2015
Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: A systematic review and meta-analysis. Respirology (Carlton, Vic.), 2016, Volume: 21, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Synergism; Drug Therapy, Combination; Humans; Macrolides; Pneumonia, Bacterial; Severity of Illness Index; Treatment Outcome	2016
Are new antibiotics better than beta-lactams for non-critical inpatients with community-acquired pneumonia? Medwave, 2016, Aug-05, Volume: 16 Suppl 3 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Costs; Drug Resistance, Bacterial; Humans; Inpatients; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome	2016
How Antibiotics Should be Prescribed to Hospitalized Elderly Patients with Community-Acquired Pneumonia. Drugs & aging, 2017, Volume: 34, Issue:1 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Fluoroquinolones; Hospitalization; Humans; Influenza Vaccines; Macrolides; Methicillin-Resistant Staphylococcus aureus; Pneumococcal Vaccines; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Time-to-Treatment	2017
Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017, Volume: 23, Issue:4 Topics: Adult; Bacteremia; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Hospitalization; Humans; Macrolides; Odds Ratio; Pneumonia, Bacterial; Shock, Septic; Treatment Outcome	2017
Health care-associated pneumonia: identification and initial management in the ED. The American journal of emergency medicine, 2008, Volume: 26, Issue:6 Suppl Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline	2008
New antimicrobial molecules and new antibiotic strategies. Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:2 Topics: Acetamides; Anti-Infective Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Humans; Ketolides; Linezolid; Lipopeptides; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic	2009
Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials. International journal of antimicrobial agents, 2010, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Community-Acquired Infections; Fluoroquinolones; Humans; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Treatment Outcome; Young Adult	2010
Does empirical therapy with a fluoroquinolone or the combination of a β-lactam plus a macrolide result in better outcomes for patients admitted to the general ward? Infectious disease clinics of North America, 2013, Volume: 27, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Hospitals, General; Humans; Macrolides; Pneumonia, Bacterial	2013
Appropriate use of the carbapenems. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	2004
Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ (Clinical research ed.), 2005, Feb-26, Volume: 330, Issue:7489 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Double-Blind Method; Humans; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome	2005
Role of beta-lactam agents in the treatment of community-acquired pneumonia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:2 Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Child, Preschool; Community-Acquired Infections; Haemophilus influenzae; Humans; Infant; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Treatment Outcome	2005
Nosocomial pneumonia. Current opinion in infectious diseases, 2006, Volume: 19, Issue:4 Topics: Aminoglycosides; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia, Bacterial	2006
Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired Pneumonia. Treatments in respiratory medicine, 2006, Volume: 5, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Humans; Legionella pneumophila; Pneumonia, Bacterial; Prospective Studies	2006
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia. The European respiratory journal, 2007, Volume: 29, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aminoglycosides; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunocompetence; Intensive Care Units; Meropenem; Pneumonia, Bacterial; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiration, Artificial; Survival Rate; Thienamycins; Treatment Outcome	2007
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome	2008
[Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam]. Medicina, 2008, Volume: 68, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Sulbactam	2008
Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors. International journal of clinical practice. Supplement, 2002, Issue:125 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Cross Infection; Drug Therapy, Combination; Humans; Pneumonia, Bacterial	2002

Trials

15 trial(s) available for beta-lactams and Pneumonia, Bacterial

Article	Year
Response Adjusted for Days of Antibiotic Risk (RADAR): evaluation of a novel method to compare strategies to optimize antibiotic use. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017, Volume: 23, Issue:12 Topics: Adult; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Bacterial; Treatment Outcome	2017
Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial. BMC infectious diseases, 2019, Jan-07, Volume: 19, Issue:1 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Female; Fluoroquinolones; Heart Diseases; Hospitalization; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies	2019
Antibiotic treatment of moderate-severe community-acquired pneumonia: design and rationale of a multicentre cluster-randomised cross-over trial. The Netherlands journal of medicine, 2014, Volume: 72, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Cross-Over Studies; Drug Therapy, Combination; Fluoroquinolones; Humans; Macrolides; Observational Studies as Topic; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Research Design; Severity of Illness Index	2014
β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA internal medicine, 2014, Volume: 174, Issue:12 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Follow-Up Studies; Hospitalization; Humans; Legionella pneumophila; Legionnaires' Disease; Macrolides; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Severity of Illness Index; Switzerland; Treatment Outcome	2014
Antibiotic treatment strategies for community-acquired pneumonia in adults. The New England journal of medicine, 2015, Apr-02, Volume: 372, Issue:14 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Cross-Over Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Intention to Treat Analysis; Length of Stay; Macrolides; Male; Middle Aged; Pneumonia, Bacterial	2015
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies. International journal of hematology, 2016, Volume: 103, Issue:3 Topics: Adult; Aged; Anti-Infective Agents; beta-Lactams; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Treatment Outcome	2016
Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial. BMC infectious diseases, 2017, 01-10, Volume: 17, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Cost-Benefit Analysis; Cross-Over Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitalization; Humans; Macrolides; Male; Middle Aged; Netherlands; Pneumonia, Bacterial	2017
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection. International journal of antimicrobial agents, 2009, Volume: 33, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Infant; Male; Molecular Sequence Data; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections	2009
Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials. International journal of antimicrobial agents, 2010, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Community-Acquired Infections; Fluoroquinolones; Humans; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Treatment Outcome; Young Adult	2010
Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2004
Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment. Infection, 2006, Volume: 34, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Doxycycline; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitalization; Humans; Levofloxacin; Macrolides; Male; Middle Aged; Moxifloxacin; Ofloxacin; Pneumonia, Bacterial; Quinolines; Treatment Failure	2006
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2006, Volume: 25, Issue:10 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities	2006
The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis. The European respiratory journal, 2007, Volume: 30, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Decision Support Techniques; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Length of Stay; Macrolides; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pneumonia, Bacterial; Probability; Prospective Studies; Severity of Illness Index; Shock, Septic; Survival Analysis; Survival Rate	2007
[Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Costs and Cost Analysis; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Meropenem; Metronidazole; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Russia; Thienamycins; Treatment Outcome	2006
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Apr-15, Volume: 34, Issue:8 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Tolerance; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome	2002

Other Studies

83 other study(ies) available for beta-lactams and Pneumonia, Bacterial

Article	Year
Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring. Journal of Korean medical science, 2022, Nov-21, Volume: 37, Issue:45 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Macrolides; Male; Pneumonia, Bacterial; Retrospective Studies; Seasons	2022
Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning. The European respiratory journal, 2019, Volume: 54, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Europe; Female; Hospitalization; Humans; Machine Learning; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Propensity Score; Prospective Studies; Severity of Illness Index; Treatment Outcome	2019
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American journal of respiratory and critical care medicine, 2019, 10-01, Volume: 200, Issue:7 Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Blood Culture; Chlamydophila Infections; Community-Acquired Infections; Culture Techniques; Drug Therapy, Combination; Haemophilus Infections; Hospitalization; Humans; Legionellosis; Macrolides; Moraxellaceae Infections; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Radiography, Thoracic; Severity of Illness Index; Sputum; United States	2019
Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study. International journal of antimicrobial agents, 2020, Volume: 55, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Cohort Studies; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2020
Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis. Scientific reports, 2019, 12-05, Volume: 9, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bacteremia; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Survival Analysis	2019
Antibiotic treatment adequacy and death among patients with Pseudomonas aeruginosa airway infection. PloS one, 2019, Volume: 14, Issue:12 Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; beta-Lactams; Denmark; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Prognosis; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome	2019
Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Humans; Intensive Care Units; Macrolides; Pneumonia, Bacterial; Propensity Score; Prospective Studies; Treatment Outcome	2021
Risk factors for complicated community-acquired pneumonia course in patients treated with β-lactam monotherapy. Advances in respiratory medicine, 2021, Volume: 89, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Female; Humans; Male; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Treatment Outcome	2021
In moderately severe CAP stable after 3 d of β-lactam, stopping therapy was noninferior to 5 additional d. Annals of internal medicine, 2021, Volume: 174, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Double-Blind Method; Humans; Pneumonia, Bacterial; Treatment Outcome	2021
Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy. International journal of antimicrobial agents, 2017, Volume: 49, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Critical Care; Critical Illness; Cross Infection; Drug Monitoring; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Renal Replacement Therapy; Retrospective Studies; Tertiary Care Centers; Young Adult	2017
Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS. BMC anesthesiology, 2017, 06-14, Volume: 17, Issue:1 Topics: Adult; Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; beta-Lactams; Bilirubin; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Respiratory Distress Syndrome; Retrospective Studies	2017
The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization. Infectious diseases (London, England), 2018, Volume: 50, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cause of Death; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Length of Stay; Logistic Models; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome	2018
Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice. PloS one, 2017, Volume: 12, Issue:8 Topics: Animals; Anti-Infective Agents; beta-Lactams; Female; Mice; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Respiratory Tract Infections	2017
Impact of antibiotic therapy in severe community-acquired pneumonia: Data from the Infauci study. Journal of critical care, 2018, Volume: 43 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Critical Illness; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Lactic Acid; Length of Stay; Logistic Models; Macrolides; Male; Middle Aged; Organ Dysfunction Scores; Pneumonia, Bacterial; Prognosis; Prospective Studies; Severity of Illness Index; Time Factors	2018
Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia. JAMA pediatrics, 2017, 12-01, Volume: 171, Issue:12 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Hospitalization; Humans; Infant; Intensive Care Units, Pediatric; Length of Stay; Macrolides; Patient Readmission; Pneumonia, Bacterial; Propensity Score; Radiography; Treatment Outcome	2017
Empiric antibiotics for community-acquired pneumonia: A macrolide and a beta-lactam please! Respirology (Carlton, Vic.), 2018, Volume: 23, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Humans; Macrolides; Pneumonia; Pneumonia, Bacterial	2018
Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection, 2018, Volume: 46, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors	2018
Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:12 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Japan; Levofloxacin; Male; Middle Aged; Pneumonia, Bacterial; Severity of Illness Index; Treatment Outcome	2019
Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Empirical Research; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Risk; Tetracycline; Urinary Tract Infections	2013
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters. Swiss medical weekly, 2013, Volume: 143 Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Guideline Adherence; Hospitalization; Humans; Immunocompromised Host; Legionnaires' Disease; Macrolides; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index	2013
Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance. Critical care (London, England), 2013, Nov-07, Volume: 17, Issue:6 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; France; Humans; Intensive Care Units; Macrolides; Male; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Prospective Studies; Risk Assessment; Survival Analysis; Time Factors	2013
Safety and efficacy of long-term outpatient ertapenem therapy. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Adult; Aged; Arthritis, Infectious; beta-Lactams; Bone and Bones; Cohort Studies; Ertapenem; Follow-Up Studies; Humans; Intraabdominal Infections; Middle Aged; Outpatients; Pneumonia, Bacterial; Retrospective Studies; Skin; Soft Tissue Infections; Surgical Wound Infection; Treatment Outcome; Young Adult	2014
[Efficiency of antibiotics in children with acute respiratory infection complicated by pneumonia dependent on the acetylation type in the Far North regions]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2014, Volume: 59, Issue:1-2 Topics: Acetylation; Acetyltransferases; Anti-Bacterial Agents; beta-Lactams; Biotransformation; Child; Child, Preschool; Cold Climate; Ethnicity; Female; Gentamicins; Humans; Male; Pneumonia, Bacterial; Polymorphism, Genetic; Respiratory Tract Infections; Russia; Treatment Outcome	2014
The debate on antibiotic therapy for patients hospitalized for pneumonia: where should we go from here? JAMA internal medicine, 2014, Volume: 174, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Legionnaires' Disease; Macrolides; Pneumonia, Bacterial	2014
Comparative Effectiveness of Beta-lactam Versus Macrolide Monotherapy in Children with Pneumonia Diagnosed in the Outpatient Setting. The Pediatric infectious disease journal, 2015, Volume: 34, Issue:8 Topics: Adolescent; beta-Lactams; Child; Child, Preschool; Female; Humans; Infant; Macrolides; Male; Outpatients; Pennsylvania; Pneumonia, Bacterial; Retrospective Studies	2015
[Community acquired pneumonia: antibiotic monotherapy is not inferior to combination therapy]. Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:13 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Macrolides; Male; Pneumonia, Bacterial	2015
Empirical Therapy of Community-Acquired Pneumonia: Advancing Evidence or Just More Doubt? JAMA, 2015, Jul-28, Volume: 314, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Legionnaires' Disease; Macrolides; Pneumonia, Bacterial	2015
Antibiotics for Community-Acquired Pneumonia in Adults. The New England journal of medicine, 2015, 08-13, Volume: 373, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Macrolides; Male; Pneumonia, Bacterial	2015
Antibiotics for Community-Acquired Pneumonia in Adults. The New England journal of medicine, 2015, 08-13, Volume: 373, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Macrolides; Male; Pneumonia, Bacterial	2015
Antibiotics for Community-Acquired Pneumonia in Adults. The New England journal of medicine, 2015, 08-13, Volume: 373, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Macrolides; Male; Pneumonia, Bacterial	2015
Antibiotics for Community-Acquired Pneumonia in Adults. The New England journal of medicine, 2015, 08-13, Volume: 373, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Macrolides; Male; Pneumonia, Bacterial	2015
Antibiotics for Community-Acquired Pneumonia in Adults. The New England journal of medicine, 2015, 08-13, Volume: 373, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Macrolides; Male; Pneumonia, Bacterial	2015
[Beta-lactam monotherapy in hospitalized pneumonia patients is not inferior to a combined therapy]. Praxis, 2015, Aug-19, Volume: 104, Issue:17 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Macrolides; Male; Pneumonia, Bacterial	2015
Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia. Pediatric pulmonology, 2016, Volume: 51, Issue:5 Topics: Adolescent; Age Factors; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Infant; Macrolides; Male; Outpatients; Pneumonia, Bacterial; Retrospective Studies; Treatment Failure; Treatment Outcome	2016
In non-ICU suspected CAP, β-lactam was noninferior to β-lactam-macrolide or fluoroquinolone for 90-d mortality. Annals of internal medicine, 2015, Sep-15, Volume: 163, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Macrolides; Male; Pneumonia, Bacterial	2015
Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database. Medicine, 2015, Volume: 94, Issue:39 Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Databases, Factual; Female; Fluoroquinolones; Humans; Insurance Claim Review; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Taiwan; Treatment Failure	2015
[Comparison of the combination and quinolone therapy in community acquired pneumonia]. Tuberkuloz ve toraks, 2015, Volume: 63, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Macrolides; Male; Pneumonia, Bacterial; Treatment Outcome	2015
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections	2016
Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair? Critical care (London, England), 2016, Jan-29, Volume: 20 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Care; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Medical Overuse; Pneumonia, Bacterial	2016
Ertapenem therapy for pneumonia requiring hospital admission in elderly people. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Ertapenem; Female; Hospital Mortality; Hospitalization; Humans; Male; Patient Discharge; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome	2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam. Clinical therapeutics, 2016, Volume: 38, Issue:9 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam	2016
Community-Acquired Pneumonia in Adults: Diagnosis and Management. American family physician, 2016, Nov-01, Volume: 94, Issue:9 Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Doxycycline; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Macrolides; Male; Oxazolidinones; Pneumonia, Bacterial; Vancomycin	2016
Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017, Volume: 23, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Comorbidity; Female; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Treatment Outcome	2017
The science of selecting antimicrobials for community-acquired pneumonia (CAP). Journal of managed care pharmacy : JMCP, 2009, Volume: 15, Issue:2 Suppl Topics: Anti-Bacterial Agents; beta-Lactams; Chlamydophila pneumoniae; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Legionnaires' Disease; Macrolides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Practice Guidelines as Topic; Streptococcus pneumoniae	2009
Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Inpatients; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2009
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?]. Medicina clinica, 2010, Oct-16, Volume: 135, Issue:12 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Ertapenem; Humans; Ofloxacin; Pneumonia, Bacterial	2010
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance	2009
Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations. International journal of antimicrobial agents, 2010, Volume: 35, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Ertapenem; Humans; Monte Carlo Method; Plasma; Pneumonia, Bacterial	2010
Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11 Topics: Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Female; Humans; Legionella pneumophila; Macrolides; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Viral; Quinolones; Sputum; Streptococcus pneumoniae; Treatment Outcome	2010
Q: Are antibiotics indicated for the treatment of aspiration pneumonia? Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactams; Clindamycin; Humans; Metronidazole; Pneumonia; Pneumonia, Aspiration; Pneumonia, Bacterial	2010
Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia. The Journal of infection, 2011, Volume: 62, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Survival Analysis; Treatment Outcome; Young Adult	2011
Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumonia. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa	2011
Diagnosis and management of community-acquired pneumonia in adults. American family physician, 2011, Jun-01, Volume: 83, Issue:11 Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Influenza Vaccines; Linezolid; Macrolides; Oxazolidinones; Pneumococcal Vaccines; Pneumonia, Bacterial; Practice Guidelines as Topic; Risk Factors; Treatment Outcome; United States; Vancomycin	2011
[Clinical efficacy of tebipenem pivoxil treatment in children with pneumonia, who had no relief despite having administered oral beta-lactam antibiotics]. The Japanese journal of antibiotics, 2011, Volume: 64, Issue:3 Topics: Administration, Oral; Amdinocillin Pivoxil; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus pneumoniae; Treatment Failure; Treatment Outcome	2011
Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; beta-Lactams; Chlamydophila; Community-Acquired Infections; Doxycycline; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Legionella; Macrolides; Male; Middle Aged; Mycoplasma; Mycoplasma Infections; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult	2012
Impact of guideline-concordant antibiotics and macrolide/β-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:3 Topics: Aged; Aged, 80 and over; Alberta; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome	2013
Procalcitonin predicts response to beta-lactam treatment in hospitalized children with community-acquired pneumonia. PloS one, 2012, Volume: 7, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Calcitonin; Calcitonin Gene-Related Peptide; Child; Child, Hospitalized; Child, Preschool; Cohort Studies; Coinfection; Community-Acquired Infections; Humans; Infant; Male; Odds Ratio; Paris; Pneumonia, Bacterial; Predictive Value of Tests; Protein Precursors; Retrospective Studies; Sensitivity and Specificity	2012
Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia. Critical care medicine, 2012, Volume: 40, Issue:8 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Length of Stay; Logistic Models; Macrolides; Male; Pneumonia, Bacterial; Practice Guidelines as Topic; Propensity Score; Retrospective Studies	2012
Antibiotic treatment for severe community-acquired pneumonia: beyond antimicrobial susceptibility. Critical care medicine, 2012, Volume: 40, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Male; Pneumonia, Bacterial	2012
Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia. The Journal of pediatrics, 2012, Volume: 161, Issue:6 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Binomial Distribution; Child; Child, Preschool; Cohort Studies; Community-Acquired Infections; Comparative Effectiveness Research; Drug Therapy, Combination; Female; Humans; Infant; Length of Stay; Logistic Models; Macrolides; Male; Patient Readmission; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome	2012
Severe community-acquired pneumonia: don't get rid of fluoroquinolone. Critical care medicine, 2013, Volume: 41, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Male; Pneumonia, Bacterial	2013
The authors reply. Critical care medicine, 2013, Volume: 41, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Male; Pneumonia, Bacterial	2013
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactams; Bronchitis, Chronic; Community-Acquired Infections; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactams; Microbial Sensitivity Tests; Pneumonia, Bacterial	2002
Short-course beta-lactam treatment for community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Mar-01, Volume: 38, Issue:5 Topics: beta-Lactam Resistance; beta-Lactams; Community-Acquired Infections; Humans; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae	2004
Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia. Pulmonary pharmacology & therapeutics, 2004, Volume: 17, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Female; Haemophilus influenzae; Hospitalization; Humans; Injections, Intravenous; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Streptococcus pneumoniae; Treatment Outcome	2004
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin	2004
A step forward in the everyday management of adults with community acquired pneumonia. BMJ (Clinical research ed.), 2005, Feb-26, Volume: 330, Issue:7489 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Double-Blind Method; Humans; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome	2005
Continuous infusion beta-lactams for intensive care unit pulmonary infections. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:5 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; United States	2005
[Resistance to penicillin and erythromycin of Streptococcus pneumoniae and Streptococcus pyogenes isolated from community-acquired respiratory infections in Spain between 1986-1999 and its relationship with the use of beta-lactams and macrolides]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2005, Volume: 18, Issue:1 Topics: beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Utilization; Erythromycin; Humans; Macrolides; Penicillin Resistance; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Spain; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes	2005
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections	2005
The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Critical care (London, England), 2005, Dec-06, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Hospital Mortality; Humans; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies	2005
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-01, Volume: 42, Issue:11 Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial	2006
Community-acquired pneumonia in Malaysian patients: addition of macrolide and the use of BTS "curb" index to assess severity. The Medical journal of Malaysia, 2006, Volume: 61, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Female; Humans; Macrolides; Malaysia; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Reproducibility of Results; Severity of Illness Index	2006
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Imipenem; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Plasmids; Pneumonia, Bacterial; Porins; Rats; Rats, Wistar; Thienamycins; Treatment Outcome	2006
[Effect of beta-lactam antibiotics in drug-induced hemolysis]. Zhongguo shi yan xue ye xue za zhi, 2006, Volume: 14, Issue:3 Topics: Aged; Anemia, Hemolytic; Anti-Bacterial Agents; beta-Lactams; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial	2006
Antibiotic treatment of community acquired pneumonia varies widely across Germany. The Journal of infection, 2007, Volume: 54, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Germany; Humans; Macrolides; Male; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Practice Patterns, Physicians'; Treatment Outcome	2007
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest, 2006, Volume: 130, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical	2006
Antibiotics selection for bacteremic pneumonia. Chest, 2007, Volume: 132, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Macrolides; Ofloxacin; Pneumonia, Bacterial; Treatment Outcome	2007
Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission. Respiratory medicine, 2007, Volume: 101, Issue:9 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Epidemiologic Methods; Female; Guideline Adherence; Humans; Length of Stay; Macrolides; Male; Middle Aged; Patient Readmission; Pneumonia, Bacterial; Practice Guidelines as Topic; Prognosis; Quinolones; Severity of Illness Index; Spain; Treatment Outcome	2007
Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Macrolides; Male; Middle Aged; New York; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome; Veterans	2007
[Atypical pneumonia: are the recommendations evidence-based?]. Archivos de bronconeumologia, 2007, Volume: 43, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Evidence-Based Medicine; Humans; Pneumonia, Bacterial	2007
Community acquired pneumonia: Antibiotic coverage is atypical: evidence from randomised trials. BMJ (Clinical research ed.), 2007, Dec-01, Volume: 335, Issue:7630 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Pneumonia, Bacterial; Randomized Controlled Trials as Topic	2007
In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:6 Topics: Acinetobacter; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Enzyme Inhibitors; Female; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin	1999